Fujifilm launches advanced endoscopy platform with new imaging capabilities

FUJIFILM Healthcare Americas Corp. announced the launch of its ELUXEO 8000 Endoscopic Imaging System, a next-generation platform designed to enhance visualization, therapeutic precision and workflow efficiency in gastrointestinal care. The system will debut at the American College of Gastroenterology 2025 Annual Scientific Meeting, Oct. 26–28 at the Phoenix Convention Center.

The ELUXEO 8000 System combines a 4K processor and light source in a single unit and features triple noise reduction, extended dynamic range, and new imaging modes intended to improve detection of abnormalities. Building on the company’s multi-light LED technology, the system introduces Amber-Red Color Imaging, designed to improve visualization of blood vessels and bleeding sources during complex procedures. It complements Fujifilm’s existing Linked Color Imaging and Blue Light Imaging modes, which support enhanced polyp detection and characterization.

“We are steadfast in our commitment to advance the field of endoscopy with innovations that empower GI physicians to safely and efficiently accomplish even the most challenging procedures with the best possible outcomes,” said Tai Fujita, vice president of the Endoscopy Division at FUJIFILM Healthcare Americas. “The ELUXEO 8000 System is our latest testament in how Fujifilm is taking endoscopic imaging to new heights.”

The platform is compatible with Fujifilm’s 500-, 600-, 700- and 800-series endoscopes, enabling facilities to upgrade imaging capabilities without replacing existing scopes. It also supports a new line of seven FDA-cleared 800-series endoscopes equipped with intelligent CMOS sensors for advanced diagnostic and therapeutic applications, including full access to the small intestine.

According to Hiroyuki Aihara, M.D., Ph.D., director of endoscopic tissue resection at Brigham and Women’s Hospital, “By emphasizing color contrast and structural detail, this new observation mode improves visual recognition of tissue layers and blood vessels when working in the submucosal space. Visualization of these structures is critical for safe and successful completion of ESD and other third space procedures.”

Recent advances in endoscopic imaging and therapeutic technology

The field of endoscopy is rapidly evolving, driven by innovations in imaging, artificial intelligence, and minimally invasive therapeutic capabilities designed to improve diagnostic accuracy and patient outcomes. One of the most significant advancements has been the integration of ultra-high-definition imaging, including 4K and higher-resolution processors, which provide greater color contrast, improved depth perception, and sharper tissue visualization. These improvements enable clinicians to identify subtle mucosal changes that may indicate early-stage disease, which is critical in gastrointestinal oncology and preventative care.

Another major focus is the development of enhanced imaging modes that use specific wavelengths of light to detect vascular and structural changes below the surface of the mucosa. These digital and optical chromoendoscopy techniques are being increasingly used during procedures such as polyp detection, tissue resection, and third-space endoscopy. The use of targeted light modes improves visibility of blood flow and tissue layers, allowing clinicians to distinguish between benign and potentially malignant lesions more effectively.

Therapeutically, endoscopic platforms are now supporting a broader range of minimally invasive interventions that historically required surgery. These include full-thickness resection, submucosal tunneling procedures, and deep enteroscopy for small bowel evaluation. Improvements in scope flexibility, torque control, and accessory tool integration have enabled safer, more precise navigation through complex anatomy.

Artificial intelligence is also emerging as a transformative tool in the endoscopy suite. AI-assisted detection algorithms can flag suspicious lesions in real time, reducing variability between operators and improving adenoma detection rates. Additionally, workflow automation and smart processors are helping clinicians streamline procedure protocols and documentation. As these technologies mature, endoscopy is transitioning from purely diagnostic to a fully integrated diagnostic-therapeutic discipline, supporting earlier intervention, reducing hospital stays, and enhancing long-term patient outcomes.